developing biomarkers and treatments for chronic joint diseases
PROJECTS
Project overview
Drug development
Biomarker development
NEWS & REPORTS
CORPORATE OVERVIEW
About AnaMar
Senior management
Board of directors
Address, phone & fax
Contact us
Search
«
Back
|
Home
»
News & Reports
»
Latest News
AnaMar News
New COMP ELISA Focus letter
26 Oct 2011, News
Focus letter 6 - Recent data suggest the existence of different phenotypic subsets of RA at clinical onset and elevated serum COMP levels should be interpreted in relation to this new approach
Read more
New COMP ELISA Focus letter
26 Oct 2011, News
New COMP ELISA Focus letter
05 Apr 2011, News
Positive Phase I results for AMAP102
01 Jun 2010, News
New COMP ELISA Focus letter
26 Mar 2010, News
AMAP102, New Oral Cytokine Inhibitor to Treat Rheumatoid Arthritis - Phase 1 dosing completed , Results in Q1
01 Dec 2009, News
AnaMar News
> Latest News
> Press releases
> Sign up for RSS-feeds
Financial reports
> Annual report 2009
> Annual report 2008
> Annual report 2007
> Annual report 2006
> Annual report 2005
> Annual report 2004
Publications
> Abstract EULAR 2010
> Abstract ACR 2009
> Abstract EULAR 2009
> Abstract ACR 2007
Press images
> People
> Logo
©
2010, AnaMar AB, Kungsportsavenyn 22, SE-411 36, Göteborg, Sweden. Phone: +46 31 732 41 40, Fax: +46 31 732 41 49,
info@anamar.com
Disclaimer
-
Privacy policy statement
-
Terms and conditions of use
